InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,687.20
(
-2.14%
)
Dow Jones
39,753.75
(
0.08%
)
Brent Oil
85.11
(
0.07%
)
Bitcoin
57,306.53
(
-0.78%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

gambler2075

Send PM Follow Ignore
Followers 49
Posts 1834
Boards Moderated 0
Alias Born 02/08/2007

gambler2075

Re: kei post# 92365

Tuesday, 01/12/2016 5:21:37 PM

Tuesday, January 12, 2016 5:21:37 PM

Post# of 97239
TTNP: Agree, IMO high likelihood of approval this time... nothing is guaranteed but... last time they cited 3 reasons why they issued a CRL... TTNP did another trial and got a positive P3, and limited the target population to the <= 8mg Buprenorphine target...

http://www.titanpharm.com/press/2013/13-04-30-Titan-CRL.htm
https://braeburnpharmaceuticals.com/braeburn-pharmaceuticals-reports-positive-results-from-phase-3-study-of-probuphine-for-opioid-addiction/

g
Discl: partial long
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up